Burling Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.27M Sell
16,795
-304
-2% -$70.8K 0.62% 38
2026
Q1
$4.18M Sell
17,099
-545
-3% -$127K 0.68% 40
2025
Q4
$3.65M Sell
17,644
-58
-0.3% -$11.5K 0.57% 47
2025
Q3
$3.28M Sell
17,702
-3,430
-16% -$588K 0.54% 50
2025
Q2
$3.23M Sell
21,132
-1,879
-8% -$289K 0.6% 49
2025
Q1
$3.82M Sell
23,011
-4,015
-15% -$628K 0.8% 40
2024
Q4
$3.91M Buy
+27,026
New +$4.19M 0.8% 38

Other funds holding JNJ

Burling Wealth Partners's JNJ Position: Q2 2026 in Review

Burling Wealth Partners reduced its Johnson & Johnson (JNJ) stake by 1.8% in Q2 2026, selling an estimated $70.8K and leaving 16,795 shares worth $4.27M. The position accounts for 0.62% of the portfolio, ranked #38.

Burling Wealth Partners first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Burling Wealth Partners held 16,795 shares of Johnson & Johnson worth $4.27M as of Q2 2026.
  • Burling Wealth Partners sold 304 Johnson & Johnson shares in Q2 2026, an estimated $70.8K.
  • Johnson & Johnson made up 0.62% of Burling Wealth Partners's portfolio in Q2 2026, its #38 holding.
  • Burling Wealth Partners first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Burling Wealth Partners's 13F filing for Q2 2026, filed 4 Aug 2026.